Levitee Labs, Inc. engages in the development and sale of high potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation. It aims to transform mental health and addiction treatments. The company was founded by Pouya Farmand, Marc Momeni, and Ken Osborne on January 23, 2019 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Levitee Labs Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Levitee Labs Inc market cap is $100.00.
What is the 52-week high for Levitee Labs Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Levitee Labs Inc 52 week high is $0.00 as of September 06, 2025.
What is the 52-week low for Levitee Labs Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Levitee Labs Inc 52 week low is $0.00 as of September 06, 2025.
What is the 50-day moving average of Levitee Labs Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Levitee Labs Inc 50-day moving average is $0.00.